PNPLA3 and fatty liver disease: The PNPLA3 I148M variant causes impaired triglyceride mobilization and accumulation of lipid droplet by evading ubiquitylation and by comparative gene identification–58 (CGI–58)–dependent inhibition of adipose triglyceride lipase, resulting in hepatic steatosis [97,98,99].